glp 1 for mash Semaglutide Receives FDA Approval Treatment of mash glp 1 Incretin-based therapies

Research published in Frontiers in Immunology demonstrated that these patients show reduced microbial diversity, decreased populations of beneficial bacteria (including Lactobacillus and Bifidobacterium species), and increased intestinal permeability, commonly known as leaky gut

And if you are feeling like you're thirsty, you're already kind of behind the game

We hypothesized that the magnitude of gastric emptying delay would be low and of limited clinical significance to procedural sedation risks

Data from the last 2 decades reveal a dramatic increase in HCC attributable to MASH (Patel and Mueller, 2025)

You may be able to save on your drug or pharmacy costs